Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD

  • Molander P
  • Sipponen T
  • Kemppainen H
 et al. 
  • 61

    Readers

    Mendeley users who have this article in their library.
  • 48

    Citations

    Citations of this article.

Abstract

Background and aims: Deep remission, meaning clinical remission with mucosal healing (MH), with anti-tumor necrosis factor-alpha (TNF-α) agents is a new target for therapy in inflammatory bowel disease (IBD). Our aim was to study how often patients on TNF-α blocking therapy actually achieve deep remission. Methods: The total of 252 IBD patients retrospectively included (183 Crohn's disease (CD), 62 ulcerative colitis (CU) or 7 inflammatory bowel disease unclassified-type colitis (IBDU)) received TNFα-antagonists (177 infliximab, 75 adalimumab) for at least 11. months and underwent ileocolonoscopy. We reviewed endoscopic and histological findings, clinical symptoms, C-reactive protein (CRP), and fecal calprotectin (FC) levels, and data on TNF-α blocking therapy. Defining deep remission as no clinical symptoms with endoscopic remission (the simple endoscopic score for Crohn's disease, SES-CD 0-2 or Mayo endoscopic subscore 0-1). Results: Of the 252 patients, 168 (67%) were in clinical remission and 122 (48%) in deep remission after a median of 23. months of maintenance therapy. Of the 183 CD patients, 117 (64%) reached clinical remission and 79 (43%) deep remission. Of the UC patients, 52 (75%) were in clinical remission and 43 (62%) in deep remission. The majority of patients in deep remission (n = 99, 81%) also had histologically inactive disease. Both median CRP and FC levels were significantly lower in patients with deep remission. Conclusion: Reassuringly, half of the IBD patients on the TNFα-blocking maintenance therapy achieved deep remission. The majority of patients in deep remission also achieved histological remission. © 2012 European Crohn's and Colitis Organisation.

Author-supplied keywords

  • Adalimumab
  • Crohn's disease
  • IBD
  • Infliximab
  • Mucosal healing
  • Ulcerative colitis

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Pauliina Molander

  • Taina Sipponen

  • Helena Kemppainen

  • Airi Jussila

  • Timo Blomster

  • Ritva Koskela

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free